The document describes the six minute walk test (6MWT), which measures the distance that a patient can quickly walk over a total of 6 minutes. The 6MWT evaluates a patient's overall functional exercise capacity and is useful for assessing patients with cardiopulmonary diseases before and after treatment. It is a self-paced test that requires only a 100ft hallway and does not use complex equipment. The document outlines how to properly perform and score the 6MWT according to standardized procedures.
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
Exercise tolerance testing (also known as exercise testing or exercise stress testing) is used routinely in evaluating patients who present with chest pain, in patients who have chest pain on exertion, and in patients with known ischaemic heart disease.
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
Exercise tolerance testing (also known as exercise testing or exercise stress testing) is used routinely in evaluating patients who present with chest pain, in patients who have chest pain on exertion, and in patients with known ischaemic heart disease.
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
Inspiratory Muscle Training or Respiratory Muscle Training or Ventilatory Muscle Training. IMT is the physiotherapy technique, with the help of different breathing exercises.
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
Inspiratory Muscle Training or Respiratory Muscle Training or Ventilatory Muscle Training. IMT is the physiotherapy technique, with the help of different breathing exercises.
How University of Utah Health's Burn Trauma ICU Eliminated Central Line Infec...University of Utah
Is zero possible? In the case of central line infections, the answer once was no. A CLABSI (central line associated blood stream infection) was once considered a car crash, or an expected inevitability of care. When University of Utah’s Burn Trauma Intensive Care Unit started treating CLABSIs like a plane crash, or a tragedy demanding in-depth investigation and cultural change, zero became possible. This presentation outlines the process and how to implement in your institution. To learn more, visit Accelerate: https://uofuhealth.utah.edu/accelerate/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
6 minute walk test
1. SIX MINUTE WALK TEST
Dr. SMITA KANASE
ASSISTANT PROFESSOR, KIMSDU, KARAD
2. INTRODUCTION
• ASSESMENT OF FUNCTIONAL CAPACITY HAS BEEN
TRADITIONALLY BEEN DONE MERELY ASKING PATIENTS
FOLLOWING:
• HOW MANY FLIGHTS OF STAIRS CAN YOU CLIMB
• HOW MANY BLOCKS CAN YOU WALK
• PATIENTS VARY IN THEIR RECOLLECTION AND MAY REPORT
OVERESTIMATIONS OR UNDERESTIMATIONS OF THEIR TRUE
FUNCTIONAL CAPACITY
3. • IN EARLY 1960’S BALKE DEVELOPED A SIMPLE TEST TO
EVALUATE THE FUNCTIONAL CAPACITY BY MEASURING THE
DISTANCE WALKED DURING A DEFINED PERIOD OF TIME.
• A 12 MINUTE FIELD PERFORMANCE TEST WAS DEVELOPED
TO EVALUATE THE LEVEL OF PHYSICAL FITNESS OF
HEALTHY INDIVIDUALS.
• THE SELF PACED 12 MWT ASSESSES THE SUBMAXIMAL
LEVEL OF FUNCTIONAL CAPACITY
4. • IN AN ATTEMPT TO ACCOMMODATE PATIENTS WITH
RESPIRATORY DISEASE FOR WHOM WALKING 12 MINUTES
WAS TOO EXHAUSTING, A 6 MWT CAME INTO BEING.
• THE 6 MWT USE A PRACTICAL SIMPLE TEST THAT REQUIRES A
100 FT HALLWAY BUT NO EXERCISE EQUIPMENT OR
ADVANCED TRAINING FOR TECHNICIANS.
5. • EVALUATES THE GLOBAL AND INTEGRATED RESPONSE OF ALL
THE SYSTEMS INVOLVED DURING EXS BUT IT DOES NOT PROVIDE
SPECIFIC INFROMATION ON FUNCTION OF EACH OF DIFFERENT
ORGANS AND SYSTEMS INVOLVED IN EXS OR THE MECHANISM OF
EXS LIMITATION.
• HOWEVER, BECAUSE MOST ACTIVITIES OF DAILY LIVING ARE
PERFORMED AT SUBMAXIMAL LEVELS OF EXERTION, THE 6 MWD
MAY BETTER REFLECT THE FUNCTIONAL EXS LEVEL FOR DAILY
PHSYICAL ACTIVITIES.
6. • IT IS A POWERFUL TOOL IN EVALUATION OF FUNCTIONAL
STATUS AND PROGNOSIS OF PATIENTS WITH A VARIETY
OF FUNCTIONAL IMPAIREMENTS.
9. TECHNICAL ASPECTS
• TEST IS PERFORMED INDOORS.
• ALONG A LONG, FLAT, STRAIGHT, ENCLOSED CORRIDOR WITH HARD
SURFACE THAT IS SELDOM TRAVELED.
• THE WALKING COURSE MUST BE 30 M IN LENGTH THUS A 100 FT HALLWAY
IS REQUIRED.
• THE LENGTH OF CORRIDOR SHOULD BE MARKED EVERY 3 M.
• THE TURN AROUND POINTS SHOULD BE MARKED WITH A CANE.
• A STARTING LINE, WHICH MARKS THE BEGINNING AND END OF EACH 30 M
LAP, SHOULD BE MARKED ON FLOOR USING BRIGHTLY COLORED TAPE.
10. PATIENT PREPARATION
• COMFORTABLE CLOTHING SHOULD BE WORN.
• APPROPRIATE SHOES FOR WALKING SHOULD BE WORN.
• PATIENTS SHOULD USE THEIR USUAL WALKING AIDS DURING TEST
(CANE, WALKER,ETC.)
• THE PATIENTS USUAL MEDICAL REGIMEN SHOULD BE CONTINUED.
• A LIGHT MEAL IS ACCEPTABLE BEFORE EARLY MORNING OR EARLY
AFTERNOON TESTS.
• PATIENTS SHOULD NOT HAVE EXERCISED VIGOROUSLY WITHIN 2 HRS OF
BEGINNING THE TEST.
11. MEASUREMENTS
• REPEAT TESTING SHOULD BE PERFORMED ABOUT THE
SAME TIME OF DAY TO MINIMIZE INTRADAY VARIABILITY.
• A WARM UP PERIOD BEFORE THE TEST SHOULD NOT BE
PERFORMED.
• PULSE OXIMETRY IS OPTIONAL. IF IT IS PERFORMED,
MEASURE AND RECORD BASELINE HEART RATE AND
OXYGEN SATURATION(SPO2).
12. • PATIENT; SITTING AT REST IN CHAIR , LOCATED NEAR THE STARTING
POSITION, FOR AT LEAST 10 MINUTES BEFORE TEST STARTS. DURING
THIS TIME CHECK FOR CONTRAINDICATIONS, MEASURE PULSE AND BP,
AND MAKE SURE THAT CLOTHING AND SHOES ARE APPORPRIATE.
• HAVE PATIENT STAND AND RATE THEIR BASELINE DYSPNEA AND
OVERALL FATIGUE USING BORG SCALE.
• SET LAP COUNTER TO ZERO AND TIMER TO 6 MINUTES.
• THEN THE PATIENT WALKING AT A COMFORTABLE PACE WALKS AND
EVERY LAP THAT IS COVERED BY HIM IS MARKED ON THE SHEET.
13. • THE PATIENT IF GETS TIRED WHILE WALKING THEN HE IS ALLOWED TO
REST BUT TIMER IS NOT STOPPED.
• THE PATIENT IS INFORMED ABOUT EVERY PASSING MINUTE BUT NO
WORDS OF ENCOURAGEMENT OR INSTRUCTIONS TO HURRY UP IS GIVEN
TO THE PATIENT.
• ONCE THE TIMER RINGS THE PATIENT IS ASKED TO STOP WHERE HE IS
AND THE FOLLOWING THINGS ARE CARRIED OUT.
• POST TEST: RECORD THE POST WALK BORG DYSPNEA AND FATIGUE
LEVEL.
• RECORD THE NUMBER OF LAPS FROM THE COUNTER.
14. • IF USING PULSE OXIMETER, MEASURE SPO2 AND PULSE
RATE FROM THE OXIMETER.
• CALCULATE THE TOTAL DISTANCE WALKED, ROUNDING
TO NEAREST METER.
• CONGRATULATE THE PATIENT ON GOOD EFFORT AND
OFFER A DRINK OF WATER.
15. BORG SCALE
• 0- NOTHING AT ALL
• 0.5- VERY, VERY SLIGHT.
• 1- VERY SLIGHT
• 2- SLIGHT
• 3- MODERATE.
• 4- SOMEWHAT SEVERE.
• 5- SEVERE.
• 6-
• 7- VERY SEVERE
• 8-
• 9-
• 10-VERY, VERY SEVERE(MAXIMAL)
16. • THIS BORG SCALE SHOULD BE PRINTED ON HEAVY PAPER
AND PREFERABLY LAMINATED.
• AT THE BEGINNING OF 6 MWT SHOW THE SCALE TO THE
PATIENT AND ASK THE PATIENT TO GRADE HIS SHORTNESS
OF BREATH AND FATIGUE ACCORDING TO THE SCALE.
17. TEST IS TERMINATED IN CASE PATIENT DEVELOPS
• CHEST PAIN
• SEVERE DYSPNEA.
• LEG CRAMPS.
• DIAPHORESIS(SWEATING, ESPECIALLY TO AN UNUSUAL
DEGREE AS A SYMPTOM.)
• PROFOUND OXYHEMOGLOBIN DESATURATION.
18. SAFETY ISSUES
• TESTING SHOULD BE PERFORMED IN A LOCATION WHERE RAPID,
APPROPRIATE RESPONSE TO AN EMERGENCY IS POSSIBLE.
• SUPPLIES THAT MUST BE AVAILABLE INCLUDE OXYGEN,
SUBLINGUAL NITROGLYCERINE, ASPIRIN AND ALBUTEROL.
• TECHNICIAN SHOULD BE CERTIFIED IN CARDIOPULOMNARY
RESUCITATION.
• IF THE PATIENT IS ON CHRONIC OXYGEN THERAPY, OXYGEN
SHOULD BE GIVEN AT THEIR STANDARD RATE.
19. FACTORS REDUCING SIX MINUTE WALK TEST.
• SHORT HEIGHT.
• OLDER AGE.
• FEMALE SEX.
• HIGHER BODY WEIGHT.
• IMPAIRED COGNITION.
• SHORT CORRIDOR I.E WALKING DISTANCE.
• PULOMNARY DISESASE(COPD, ASTHMA, CYSTIC FIBROSIS, INTERSTITIAL LUNG
DISEASE)
• MUSCULOSKELETAL DISORDERS.
• CARDIOVASCULAR DISEASE(ANGINA, MI, CHF, STROKE, PVD)
20. FACTORS INCREASING SIX MINUTE WALK TEST
• MALE SEX.
• HIGHER MOTIVATION.
• TALLER HEIGHT OR LONG LEGS.
• A PERSON WHO HAS PERFORMED THE TEST PREVIOUSLY.
• MEDICATION FOR A DISABILING DISEASE TAKEN JUST
BEFORE THE TEST.
21. CONCLUSION
• THE 6 MWT IS USEFUL MEASURE OF FUNCTIONAL CAPACITY
TARGETED AT PEOPLE WITH AT LEAST MODERATELY SEVERE
IMPAIREMENT. THE TEST HAS BEEN WIDELY USED FOR
PREOPERATIVE AND POSTOPERATIVE EVALUATION AND FOR
MEASURING THE RESPONSE TO THERAPEUTIC
INTERVENTIONS FOR PULMONARY AND CARDIAC DISEASE